Yong-ming, Z., Zhen-qiao, H., Ming-hui, H. et al. Clinical study on the effect of Shengxueling on idiopathic thrombocytopenic purpura., Chin. J. Integr. Med. 11, 60–64 (2005). https://doi.org/10.1007/BF02835753
Zhou Yong-ming, Huang Zhen-qiao, Hu Ming-hui, et al. Clinical study on the effect of Shengxueling on idiopathic thrombocytopenic purpura[J]. Chinese Journal of Integrative Medicine, 2005,11(1):60-64.
Yong-ming, Z., Zhen-qiao, H., Ming-hui, H. et al. Clinical study on the effect of Shengxueling on idiopathic thrombocytopenic purpura., Chin. J. Integr. Med. 11, 60–64 (2005). https://doi.org/10.1007/BF02835753DOI:
Zhou Yong-ming, Huang Zhen-qiao, Hu Ming-hui, et al. Clinical study on the effect of Shengxueling on idiopathic thrombocytopenic purpura[J]. Chinese Journal of Integrative Medicine, 2005,11(1):60-64. DOI: 10.1007/BF02835753.
Clinical study on the effect of Shengxueling on idiopathic thrombocytopenic purpura
摘要
Objective: To observe the clinical effect of Shengxueling (SXL) on idiopathic thrombocytopenic purpura (ITP)
and study the possible mechanism.Methods: Eighty-six cases of ITP were randomly divided into two groups. The SXL group
56 patients treated with SXL
a traditinal Chinese medicine and 30 patients administered with prednisone were taken as control. Each group took drugs for 3 months and was under follow-up observation.Results: In the SXL group
the total effective rate was 85. 71%
similar to prednisone 83. 33%(P>0. 05) for 3 months
but the total effective rate of SXL (91.07%) were obviously better than that of the control group (53. 33%) (P<0.01) for 6 months and had no obvious adverse reaction. The patients bleeding was alleviated or stopped
the general condition was improved. At the same time
blood platelet count (PLT) was increased
platelet associated immunoglobulin (PAIg) and interleukin-4 (IL-4) were markedly dropped
the level of natural killers cells activity (NKa) increased
the rate of T lymphocyte subsets gradually returned to normal level. Megakaryocyte tended to maturation on bone marrow smear after treatment. All differences above were statistically significant.Conclusion: SXL is an effective and safe medicine for ITP. Its mechanism could regulate cytoimmune
inhibit platelet antibody to reduce the destruction of platelet
increase the number of platelet
promote the division and maturation of megakaryocyte
facilitate the production and release of platelet
lower the fragility of capillary
prevent and cure hemorrhagic tendency.
Abstract
Objective: To observe the clinical effect of Shengxueling (SXL) on idiopathic thrombocytopenic purpura (ITP)
and study the possible mechanism.Methods: Eighty-six cases of ITP were randomly divided into two groups. The SXL group
56 patients treated with SXL
a traditinal Chinese medicine and 30 patients administered with prednisone were taken as control. Each group took drugs for 3 months and was under follow-up observation.Results: In the SXL group
the total effective rate was 85. 71%
similar to prednisone 83. 33%(P>0. 05) for 3 months
but the total effective rate of SXL (91.07%) were obviously better than that of the control group (53. 33%) (P<0.01) for 6 months and had no obvious adverse reaction. The patients bleeding was alleviated or stopped
the general condition was improved. At the same time
blood platelet count (PLT) was increased
platelet associated immunoglobulin (PAIg) and interleukin-4 (IL-4) were markedly dropped
the level of natural killers cells activity (NKa) increased
the rate of T lymphocyte subsets gradually returned to normal level. Megakaryocyte tended to maturation on bone marrow smear after treatment. All differences above were statistically significant.Conclusion: SXL is an effective and safe medicine for ITP. Its mechanism could regulate cytoimmune
inhibit platelet antibody to reduce the destruction of platelet
increase the number of platelet
promote the division and maturation of megakaryocyte
facilitate the production and release of platelet
lower the fragility of capillary
prevent and cure hemorrhagic tendency.
关键词
ShengxuelingIdiopathic Thrombocytopenic PurpuraTraditional Chinese Medicine Therapy
Keywords
ShengxuelingIdiopathic Thrombocytopenic PurpuraTraditional Chinese Medicine Therapy
references
Zhang ZN, Shen D. Hematology diagnosis and therapeutic effect criteria. 2nd ed. Beijing: Science Press, 1999: 279–282.
Chen BY, Ma JY, Huang QT, et al. Modification of simple nature killer test — LDH release. J Shanghai Immunol 1989;(4): 201, 218–219.
Zhang MH, Song SQ, Zhang D, et al. Comparison between lymphocyte leukemia immunity type by immunity enzyme staining method. Chin J Hematol 1990; (11): 40–41.
The National Association of TCM, Internal Medicine Society. The criteria of bleeding grading in ITP. J Beijing Coll TCM 1984;7(4): 25–27.
Vignaux F, Golstein P. Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway. Eur J Immunol 1994;24: 923–927.
McFarland J. Pathophysiology of platelet destruction in immune (idiopathic) thrombocytopenic purpura. Blood Rev 2002;16: 1–2.
A clinical study on global TCM therapy in treating senile advanced non-small cell lung cancer
Effect of Tiaozhi Yanggan Decoction (调脂养肝汤) in treating patients with non-alcoholic fatty liver
Research and development of new Chinese materia medica for treatment of refractory hematopathy by establishment and application of multiple technique platforms
Treatment of 37 patients with refractory idiopathic thrombocytopenic purpura by Shengxueling (升血灵)
A survey on treatment of dry eye by traditional chinese medicine and integrative Chinese and Western medicine
相关作者
暂无数据
相关机构
Guangdong Provincial Traditional Chinese Medicine Hospital
People’s Hospital of Ruyang County
The First Affiliated Hospital of Henan College of Traditional Chinese Medicine
Traditional Chinese Medicine Hospital of Ruyang County
Institute of Hematology, The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine